This product GTTS-WQ6377MR is a type of mRNA modified with Pseudo-UTP, which ecodes the monoclonal antibody that targets Factor IX substitute gene. The antibody can be applied in Hemophilia B research.
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-Factor IX substitute, CSL654(Cap 0, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WQ6377MR). Click the button above to contact us or submit your feedback about this product.
